Financhill
Back

Nektar Therapeutics Stock Price Chart

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing buying pressure, which is a positive indicator for future bullish movement.

Nektar Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 43.77 Sell
20-day SMA: 49.67 Sell
50-day SMA: 55.41 Sell
200-day SMA: 32.6 Buy
8-day EMA: 44.09 Sell
20-day EMA: 48.29 Sell
50-day EMA: 51.6 Sell
200-day EMA: 38.68 Buy

Nektar Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.04 Sell
Relative Strength Index (14 RSI): 35.41 Sell
Chaikin Money Flow: 543931 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.54 - 59.5) Sell
Bollinger Bands (100): (38.31 - 62.31) Sell

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Nektar Therapeutics Stock

Is Nektar Therapeutics Stock a Buy?

NKTR Technical Analysis vs Fundamental Analysis

Sell
45
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy or a Sell?

Nektar Therapeutics Stock Info

Market Cap:
731.5M
Price in USD:
42.28
Share Volume:
900K

Nektar Therapeutics 52-Week Range

52-Week High:
66.92
52-Week Low:
6.48
Sell
45
Nektar Therapeutics (NKTR) is a Sell

Nektar Therapeutics Share Price Forecast

Is Nektar Therapeutics Stock a Buy?

  • Nektar Therapeutics share price is 42.28 while NKTR 8-day exponential moving average is 44.09, which is a Sell signal.
  • The stock price of NKTR is 42.28 while Nektar Therapeutics 20-day EMA is 48.29, which makes it a Sell.
  • Nektar Therapeutics 50-day exponential moving average is 51.60 while NKTR share price is 42.28, making it a Sell technically.
  • NKTR stock price is 42.28 and Nektar Therapeutics 200-day simple moving average is 38.68, creating a Buy signal.

Fundamental Analysis of Nektar Therapeutics

Is Nektar Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.54 per share, and a decrease next year of $2.39 per share.

Technical Analysis of Nektar Therapeutics

Should I short Nektar Therapeutics stock?

* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.